Thailand’s COVID-19 Vaccine ChulaCov19 Expected in 2024
BANGKOK, Sept 15 (TNA) – Thailand’s homegrown COVID-19 vaccine would complete trial processes next year and its use was expected...
ChulaCov19 Vaccine
First lot of local ChulaCov19 vaccine produced
The first batch of ChulaCov19, the first messenger-RNA vaccine developed in Thailand, has been produced and is awaiting Food and...
‘ChulaCov19’ Thailand’s first COVID-19 vaccine to enter third phase of trials
Chulalongkorn University’s Centre of Excellence in Vaccine Research and Development expects to register its mRNA Covid-19 vaccine, known as ChulaCOV-19,...
ChulaCov19 COVID Vaccine as Effective as Pfizer’s
BANGKOK, Aug 16 (TNA) – The ChulaCov19 vaccine proved to be as effective as the Pfizer vaccine when it comes...
Chula Medicine Announced the Success of Clinical Trials for the ‘ChulaCov19’ Vaccine and Acceleration of the Next Phase of Research
August 16, 2021 – Chulalongkorn Memorial Hospital, Thai Red Cross Society, and the Vaccine Research Center, Faculty of Medicine, Chulalongkorn...
Applications for Thailand’s ‘ChulaCov19’ Vaccine Trial Volunteers Closes before Due Date
BANGKOK (NNT) - The Faculty of Medicine at Chulalongkorn University has announced the closure of applications for volunteers to trial...
“ChulaCov19” Thailand’s First COVID-19 Vaccine Has Been Tested on Humans
On June 14, 2021 at Bhumisirimangalanusorn Building, Chulalongkorn Memorial Hospital, the Thai Red Cross Society, the Faculty of Medicine and...
Human Trial Starts for ChulaCov19 Vaccine
BANGKOK, June 15 (TNA) – Chulalongkorn University on Monday started the human trial of its ChulaCov19 vaccine after successfully doing...
